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An epidemic of proteinuria in Pima Indians with Type 2 diabetes
mellitus.
Background. The risk of proteinuria in Type 1 diabetes declined
$30% over the past 50 years, and improvements in metabolic
control are believed to be largely responsible. Little is known
about secular changes in the risk of proteinuria in Type 2 diabetes.
Methods. We examined trends in the incidence rate of protein-
uria in Pima Indians $20 years of age with diabetes diagnosed
between January 1, 1955 and December 31, 1994.
Results. Among 1305 initially non-proteinuric diabetic subjects,
433 developed proteinuria during a median follow-up of 8.0 years
(range 0.8 to 30.2 years). With subjects with diabetes diagnosed
between 1955 and 1964 serving as the reference group, the rate of
proteinuria was similar (rate ratio 1.0; 95% confidence interval,
0.79 to 1.3) in the cohort diagnosed between 1965 and 1974, 1.5
times as high (95% confidence interval, 1.1 to 2.0) in the cohort
diagnosed between 1975 and 1984, and 1.9 times as high (95%
confidence interval, 1.1 to 3.0) in the cohort diagnosed between
1985 and 1994, after adjusting for potential confounders in a
generalized additive proportional hazards model. Between the
first and last cohorts, plasma glucose concentration declined, on
average, by 17% (P 5 0.0001) and the mean arterial pressure
declined by 11% (P 5 0.0001).
Conclusions. The incidence rate of proteinuria in Pima Indians
with Type 2 diabetes increased nearly twofold in the last 40 years,
despite improvements in plasma glucose and blood pressure.
Rapidly changing environmental or behavioral factors must play
an important role in the pathogenesis of diabetic renal disease in
this population.
Changes in attitudes towards metabolic regulation, the
introduction of purified insulin preparations, and the wide-
spread use of blood glucose monitoring are believed to be
largely responsible for a 30 to 50% decline in the risk of
proteinuria among patients diagnosed with Type 1 diabetes
in the 1940s and 1950s compared to those diagnosed in the
1930s [1–3]. More aggressive glycemic control in recent
years contributed to a further decline in some populations.
Bojestig and coworkers reported that the 25-year cumula-
tive incidence of proteinuria declined from 30% in patients
diagnosed with diabetes between 1961 and 1965 to 9% in
those diagnosed between 1966 and 1970 [4]. The level of
glycemic control achieved in these patients improved dur-
ing the 1980s, to become equivalent to that found in
subjects receiving intensive treatment in the Stockholm
Diabetes Intervention Study [5] and the Diabetes Control
and Complications Trial (DCCT) [6]. The delivery of
intensive management, however, presents major practical
challenges, and in clinics where optimal glycemic control
was not achieved, the incidence rate of proteinuria re-
mained unchanged in patients diagnosed with diabetes
after 1965 [7, 8].
Secular changes in the incidence rate of proteinuria are
not described as extensively in Type 2 diabetes. Ballard and
coworkers reported that the rate of proteinuria in the
mostly Caucasian subjects of Rochester, Minnesota was
unchanged in those with diabetes diagnosed between 1945
and 1969, despite a decline in the rate of retinopathy in the
same cohort that might be attributable to improvements in
diabetes care [9, 10]. They suggested that changes in the
incidence rate of proteinuria attributable to diabetes may
be difficult to identify in Type 2 diabetes because these
patients are typically older than those with Type 1 diabetes,
and so they are more prone to have diseases other than
diabetes that cause proteinuria [9].
In Pima Indians, Type 2 diabetes characteristically de-
velops at an earlier age than in Caucasians [11], and nearly
all of the renal disease is attributable to diabetes [12–14]. In
addition, frequent oral glucose tolerance testing of most
members of the population over the past 32 years permits
the onset and duration of diabetes to be determined with
greater certainty than in most populations [15]. Conse-
quently, trends in the incidence rate of proteinuria attrib-
utable to Type 2 diabetes are less likely to be obscured by
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other causes of proteinuria and by inaccuracies in estimat-
ing the onset of diabetes. The present study examines
trends in the incidence rate of proteinuria in Pima Indians
with Type 2 diabetes.
METHODS
Subjects
Pima and the closely related Tohono O’odham Indians
from the Gila River Indian Community participate in a
longitudinal diabetes study [15]. Since 1965, each member
of the Community who is five years old or more is asked to
have a research examination every two years. These exam-
inations include a glucose tolerance test with determination
of the glucose concentration in venous plasma drawn after
an overnight fast and two hours after a 75 g oral carbohy-
drate load. Diabetes was defined according to criteria of the
Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus [16]. The date of diagnosis was deter-
mined from the research examinations, or from review of
clinical records if diabetes was diagnosed in the course of
routine medical care.
Urine specimens collected at the end of the two-hour
glucose tolerance test are tested for protein by dipstick
(Labstix; Ames Co., Elkhart, IN, USA). Those containing
at least a trace of protein are tested quantitatively for total
protein by the Shevky-Stafford method [17]. Creatinine
concentration is measured in the same specimen using a
modification of the picrate method of Jaffe [18], and a
urinary protein-to-creatinine ratio (g protein/g creatinine)
is computed. The creatinine concentration was measured at
the endpoint of the creatinine-picrate reaction until July
1992 when it was replaced by a kinetic method. Proteinuria
was defined as a protein-to-creatinine ratio of at least 0.5
g/g, equivalent to a total protein excretion rate of approx-
imately 500 mg or more per day [19–21]. The date of onset
of proteinuria was considered to be the midpoint between
the date of the first research examination after the onset of
diabetes at which proteinuria was identified and the date of
the previous diabetic examination.
Arterial blood pressure was measured once in the right
arm by a physician or nurse practitioner using a mercury
sphygmomanometer equipped with a large adult cuff with
the subject resting in the supine position. Systolic and
diastolic blood pressures were recorded to the nearest 2
mm Hg, and diastolic pressure was measured at the fourth
Korotkoff sound. Mean arterial blood pressure was calcu-
lated as the diastolic pressure plus one-third of the pulse
pressure.
The study population included 1305 non-proteinuric
Pima and Tohono O’odham Indians $20 years old with
Type 2 diabetes who had two or more research examina-
tions and were diagnosed with diabetes between January 1,
1955 and December 31, 1994. Subjects diagnosed between
1955 and 1964 were all diagnosed in the course of routine
medical care, since the longitudinal research study did not
start until 1965.
Statistical analysis
Incidence rates of proteinuria were calculated as the
number of subjects who developed proteinuria divided by
the person-years of follow-up, and expressed per 1000/year.
The period of risk extended from the date of the first
examination after the onset of diabetes to the date of onset
of proteinuria or, if the subject had not developed protein-
uria, to the date of the last examination. One hundred
eighty-four subjects with proteinuria at their first examina-
tion at which they had diabetes were not included in the
study. Person-time was accumulated for each subject be-
tween research examinations, and time-dependent changes
in covariate values were taken into account.
Cumulative incidence was calculated from the incidence
rates for each interval of diabetes duration. These cumu-
lative incidences represent the proportions of subjects who
would have proteinuria at the end of each interval of
diabetes duration if there were no spontaneous remission
of proteinuria, no selective mortality, and the duration-
specific incidence rates of proteinuria were constant
throughout the follow-up period. The cumulative incidence
and its standard error at the end of each interval were
estimated, assuming that the observations in each interval
were independent of those in the previous intervals [22].
The variances of the duration-specific estimates were cu-
mulated to derive the variances of the cumulative inci-
dences [23].
Subjects were divided into four groups according to the
calendar year of diabetes diagnosis; 1955 to 1964, 1965 to
1974, 1975 to 1984, and 1985 to 1994. Mean values for
two-hour post-load plasma glucose concentration, mean
arterial pressure, body mass index, and serum cholesterol
concentration in each cohort were computed at the first
examination after the onset of diabetes by analysis of
covariance, after setting the values of the covariates (age,
sex, and duration of diabetes) to the sample means. In
subjects diagnosed between 1955 and 1964, the first exam-
ination occurred several years after the onset of diabetes,
since the longitudinal research study did not start until
1965.
The secular change in the risk of proteinuria was exam-
ined using a Cox proportional hazards model to control for
the effects of potentially confounding variables. These
variables included age, sex, duration of diabetes, two-hour
post-load plasma glucose concentration, mean arterial
blood pressure, serum cholesterol concentration, body
mass index, and treatment with oral hypoglycemic medi-
cines or insulin. One subject with missing data for some of
these variables at the baseline examination was not in-
cluded in the study. The proportional hazards model is
expressed in terms of the hazard (incidence rate)
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h(tuxil,..., xip)
defined as the probability that an individual with covariates
xil ,. . ., xip develops proteinuria in a short time interval after
time (t), given survival to time t. The (linear) proportional
hazards model expresses the hazard rate as




where h0(t) is an unspecified baseline hazard function.
Since the secular trend in the rate of proteinuria–and other
covariates–may be described more accurately by a non-
loglinear relationship, a generalized additive proportional
hazards model was used in the present analyses. This model
relaxes the linearity assumptions and allows smooth non-
linear functions of the covariates to be included in the log
hazard ratio. The generalized additive proportional haz-
ards model has the form




where the fj’s are smooth functions. Each fj is estimated in
a flexible manner using scatterplot smoothers [24, 25]. This
modeling approach is capable of handling both linear and
smoothed terms. A smoothed term was used for the
duration of diabetes, but not for age, mean arterial pres-
sure, two-hour post-load plasma glucose concentration,
serum cholesterol concentration, or body mass index, since
inspection of additive function plots and statistical testing
of the nonlinearity of effect suggested that only duration
had an important non-loglinear association with the out-
come. The date of onset of diabetes was included as a
smoothed term so its relationship with the outcome could
be examined without the loglinear constraints imposed by
conventional proportional hazards analysis. Continuous
variables included in the regression models were centered
at their mean baseline values, and categorical variables,
with the exception of the decade of diabetes diagnosis, were
coded so that the largest category was the reference group.
The decade from 1955 to 1964 served as the reference
category for this group of variables. If values for variables
changed at subsequent examinations, the new values were
included for the appropriate time periods. Product terms of
predictor variables did not improve the regression models
and were not included.
RESULTS
Of 1305 non-proteinuric diabetic subjects (487 men, 818
women) $20 years of age, 433 (149 men, 284 women)
developed proteinuria during a median follow-up of 8.0
years (range 5 0.8 to 30.2 years). At the baseline examina-
tion, 318 subjects (25%) were treated with antihypertensive
medicines; data on antihypertensive medicines were miss-
ing in 26 subjects. Clinical and demographic features of the
study population are shown in Table 1.
Incidence rates of proteinuria are presented in Table 2
according to age and sex. In general, the incidence rate was
higher in the older subjects and similar in men and women,
although there was a tendency for the rate in subjects ,50
years of age to be higher in the men and in those $50 years
of age to be higher in the women. The incidence rate rose
with increasing duration of diabetes, from 10.4 per 1000/
year in the first five years of diabetes to 144 per 1000/year
after 25 to 29 years of diabetes (Fig. 1). The predicted
cumulative incidence was 17% (95% confidence interval, 14
to 19) after 10 years, 60% (95% confidence interval, 56 to
64) after 20 years, and 87% (95% confidence interval, 80 to
92) after 30 years of diabetes duration (Fig. 2).
Figure 3 shows the incidence rate of proteinuria accord-
ing to duration of diabetes and the decade in which
diabetes was diagnosed. Among the subjects diagnosed
with diabetes during the longitudinal research study period
(1965–1994), those with the most recent onset of diabetes
(1985–1994) had the highest duration-specific incidence
rates of proteinuria. Subjects diagnosed prior to the start of
routine glucose tolerance testing (1955–1964), who were
diagnosed in the course of medical care, had duration-
specific incidence rates similar to those in subjects diag-
nosed between 1965 and 1974.
Mean values for two-hour post-load plasma glucose
concentration, mean arterial pressure, body mass index,
and serum cholesterol concentration in each cohort at the
first examination after the onset of diabetes are shown in
Table 3, adjusting for age, sex, and duration of diabetes. In
general, the two-hour post-load plasma glucose concentra-
tion, the mean arterial pressure, and the serum cholesterol
concentration were lower, and the degree of obesity was
higher in successive cohorts. Between the first and last
cohorts, the two-hour post-load plasma glucose concentra-
tion declined, on average, by 17% from 363 mg/dl to 303
mg/dl (P 5 0.0001), mean arterial pressure by 11% from
104 mm Hg to 93 mm Hg (P 5 0.0001), and serum
cholesterol concentration by 7% from 194 mg/dl to 181
Table 1. Baseline clinical and demographic features of the 1305 Pima
Indians (487 men, 818 women) in the study population
Mean
(SD) Range
Age years 42 (13) 20–88
Duration of diabetes years 2.0 (3.3) 0–22.9
Body mass index kg/m2
Men 33 (7) 19–84
Women 36 (7) 20–73
Mean arterial pressure mm Hg 97 (14) 51–159
Two-hour plasma glucose mg/dl 316 (125) 77–1150
Serum cholesterol mg/dl 181 (38) 78–422
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mg/dl (P 5 0.002). The body mass index increased by 13%
from 32.2 kg/m2 to 36.5 kg/m2 (P 5 0.0001).
When examined as a continuous variable in a generalized
additive proportional hazards model, the date of onset of
diabetes was strongly associated with the incidence rate of
proteinuria (P 5 0.005), adjusting for age, sex, duration of
diabetes, mean arterial pressure, two-hour plasma glucose
concentration, body mass index, serum cholesterol concen-
tration, and treatment with oral hypoglycemic medicines or
insulin. The rate of proteinuria appears to have declined
slightly in those diagnosed with diabetes in the late 1950s
and early 1960s, but increased steadily thereafter (Fig. 4A).
With subjects diagnosed between 1955 and 1964 serving as
the reference group, the rate of proteinuria was similar
(rate ratio 1.0; 95% confidence interval, 0.79 to 1.3) in
those diagnosed between 1965 and 1974, 1.5 times as high
(95% confidence interval, 1.1 to 2.0) in those diagnosed
between 1975 and 1984, and 1.9 times as high (95%
confidence interval, 1.1 to 3.0) in those diagnosed between
1985 and 1994 (Table 4). The incidence rate of proteinuria
also increased rapidly with increasing duration of diabetes
until after about 15 years of diabetes (Fig. 4B).
DISCUSSION
Pima Indians with Type 2 diabetes are extraordinarily
susceptible to diabetic renal disease. Unlike Type 1 diabe-
tes, in which the incidence rate of proteinuria increases
initially and then declines after about 15 years of diabetes
[2, 26, 27], the incidence rate in this population did not
decline through 30 years of diabetes duration. The pre-
dicted cumulative incidence of proteinuria after 30 years of
diabetes was 87%, suggesting that most diabetic Pima
Indians will eventually develop renal disease if they do not
first die of another disease. Even so, the cumulative inci-
dence may underestimate the risk in the latter part of the








20–29 8 373.3 21 12 631.7 19
30–39 31 1,005.8 31 32 1,635.5 20
40–49 54 1,219.1 44 71 2,117.7 34
50–59 25 826.9 30 84 1,981.2 42
60–69 22 496.8 44 69 1,149.7 60
$70 9 223.3 40 16 345.0 46
Total 149 4,145.2 36 284 7,860.8 36
Fig. 1. Incidence rate (per 1000/year) of proteinuria in Pima Indians
>20 years of age according to the duration of diabetes.
Fig. 2. Cumulative incidence (%) and 95% confidence interval of protein-
uria in Pima Indians >20 years of age according to the duration of
diabetes.
Fig. 3. Incidence rate (per 1000/year) of proteinuria in Pima Indians
>20 years of age according to duration of diabetes and the date of onset
of diabetes: 1955 to 1964 (- - -), 1965 to 1974 (–), 1975 to 1984(—), and
1985 to 1994 (— - —).
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study, because it is calculated from the duration-specific
incidence rates under the assumption that these rates were
constant throughout the follow-up period. The incidence
rate of proteinuria, however, increased during the time
interval of the study. The risk of proteinuria was nearly two
times as high in subjects diagnosed with diabetes after 1985
than in those diagnosed between 1955 and 1964. The
increasing rate is not due to a declining death rate, since
the overall death rate in the Pima Indians is unchanged
[28]. The rising death rate from ischemic heart disease in
this population [28] would probably not affect the changes
in the incidence rate of proteinuria, as ischemic heart
disease typically occurs after the development of protein-
uria. A secular increase in the incidence rate of proteinuria
of this extent has not been reported previously in patients
with Type 2 diabetes. Although genetic factors may en-
hance the susceptibility to renal disease in Type 2 diabetes
[29–31], the magnitude of the change over a span of only 40
years suggests that powerful nongenetic forces are involved.
Hyperglycemia and blood pressure are well-recognized
risk factors for proteinuria in Type 2 diabetes, both in the
Pima Indians [32, 33] and in other populations [9, 34]. In
addition, hyperlipidemia is implicated in the development
and progression of diabetic renal disease [35–38]. Each of
these factors is positively related to the development of
proteinuria in the present study (Table 4), but they do not
explain the rising incidence rate of proteinuria, since the
initial plasma glucose concentration, mean arterial pres-
sure, and serum cholesterol concentration after the onset of
diabetes were, on average, lower in subjects diagnosed with
diabetes more recently than in those diagnosed in earlier
years (Table 3). Moreover, unlike the majority of subjects
diagnosed with diabetes during the study period (1965–
1994) those diagnosed prior to the start of routine glucose
tolerance testing (1955–1964) had the benefit of several
years of diabetes care before these variables were measured
at a research examination, so improvements in glucose and
blood pressure at the onset of diabetes may be even greater
than the results suggest. Therefore, other factors must be
considered to explain the rising incidence rate of protein-
uria found in this study.
Substantial changes in physical activity and dietary pat-
terns may have occurred in the population during the study
period, since the body mass index in subjects diagnosed
with diabetes after 1985 was 13% higher, on average, than
in those diagnosed prior to 1965. Changes in obesity in the
study cohort are consistent with trends in the Pima popu-
lation as a whole [39], which has experienced a dramatic
increase in the degree of obesity since the turn of the
century. Over the same period, the traditional Pima diet of
grains, squash, melons and legumes, supplemented by
gathered desert plants [40, 41] has evolved to a diet
distributed among the major nutrients in proportions sim-
ilar to the typical United States diet [42]. Studies in
experimental animals suggest that long-term high-protein
diets accelerate structural and functional injury within the
kidney, whereas low protein diets offer renoprotection
[43–45]. Moreover, morbid obesity may itself lead to
proteinuria, glomerular hypertrophy, and focal and seg-
mental glomerular sclerosis [46–48]. Although the roles of
diet and exercise in the changing incidence rate of protein-
uria in this population have not been assessed, obesity, as
judged by the body mass index, was not a risk factor for
proteinuria (Table 4). This suggests that obesity, and
changes in diet and exercise that influence the degree of
obesity are not primarily responsible for the dramatic
secular changes that were observed.
Intrauterine exposure to diabetes increases the risk that
the offspring will develop diabetes before they reach the
childbearing years [49]. Pettitt and Knowler proposed that
this relationship leads to a vicious cycle in which each
successive generation has a higher risk of having diabetes
by the time it reaches childbearing age than the preceding
generation [50]. We found recently that the risk of elevated
urinary albumin excretion is nearly four times as high in
diabetic Pima Indians exposed to diabetes in utero than in
those who were not exposed [51]. Although the effect of
exposure to diabetes in utero on the fetal kidney has not
been studied, it is possible that the rise in the incidence rate
of renal disease seen in the present study is due, at least in
part, to an increasing frequency of diabetic pregnancies in
successive generations. In patients who already possess an
underlying susceptibility to diabetic renal disease, a fuel-
mediated teratogenic effect [52] of exposure to diabetes in
utero may lead to earlier development of renal disease and
more rapid progression of disease in adulthood once
diabetes develops. Perhaps this exposure impairs nephron
development, leading to a reduction in the glomerular
Table 3. Age-sex-duration adjusted mean valuesa (SE) for two-hour post-load plasma glucose concentration, mean arterial pressure, body mass










1955–64 195 363 (10) 104 (1) 194 (3) 32.2 (0.5)
1965–74 441 327 (6) 100 (1) 184 (2) 33.4 (0.3)
1975–84 383 298 (6) 94 (1) 177 (2) 34.3 (0.3)
1985–94 286 305 (7) 93 (1) 181 (2) 36.5 (0.4)
Subjects are divided into four groups according to the calendar year of diabetes diagnosis.
a Analysis of covariance; values for age, sex, and duration of diabetes were set to the sample means.
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surface area available for filtration. The extent to which
intrauterine exposure to diabetes is responsible for the
increasing incidence rate of proteinuria in this population,
however, cannot be determined, because data on maternal
diabetes during pregnancy over several generations are not
available.
A slight male preponderance in the risk of proteinuria
was found in the present study, in keeping with a slightly
higher risk of diabetic end-stage renal disease in Pima men
[12]. In addition, treatment with either oral hypoglycemic
medicines or insulin was associated with a substantial
increase in the risk of proteinuria, presumably reflecting
the increased severity of diabetes in subjects receiving these
medicines or possibly an adverse effect of diabetes treat-
ment on the kidney.
Systematic oral glucose tolerance tests performed
throughout the study permit us to identify the onset and
duration of Type 2 diabetes with a degree of certainty not
found in other studies. The estimates of duration, however,
are less accurate in subjects examined infrequently than in
those seen every two years. In addition, the duration of
diabetes is more likely to be underestimated in subjects
diagnosed in the course of routine medical care before 1965
and in those first diagnosed at their initial research exam-
ination, because they do not have research examinations
prior to the one at which they were diagnosed with diabe-
tes. Given the strong association between diabetes duration
and the incidence rate of proteinuria, an underestimate of
the duration of diabetes will result in an overestimate of the
incidence rate of proteinuria for a given duration of
Fig. 4. Function plots for the effect of
smoothed terms (A) year of onset and (B)
duration of diabetes on the incidence rate of
proteinuria in the additive proportional
hazards model. Each curve is centered to have
an average of zero over the range of the data.
The dashed lines indicate approximate
pointwise 95% confidence intervals.
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diabetes. Since the degree of misclassification of diabetes
duration is likely to be greater in subjects diagnosed during
the first part of the study, this misclassification would tend
to reduce the secular difference in duration-specific rates.
An analysis limited to the 591 subjects in whom the
duration of diabetes was known with greatest certainty–
those with a nondiabetic examination within five years of
the one at which diabetes was diagnosed–shows the same
increasing secular trend in the incidence rate of proteinuria
as in the larger cohort (data not shown), suggesting that the
extent of misclassification of diabetes onset and duration
introduced by variability in the frequency of examinations is
small. Nevertheless, since proteinuria was also determined
at the research examinations, variability in the frequency of
examination and loss to follow-up could lead to either an
underestimate or an overestimate of changes in the inci-
dence rate of proteinuria.
Pima Indians who chose not to participate in the re-
search examinations may have a different incidence rate of
proteinuria than those who volunteered. Quantitative mea-
sures of proteinuria are not consistently available in the
clinical records, so it was not possible to estimate the
incidence rate in the non-participants. However, patients
who progress to end-stage renal disease are identified
independently of research clinic attendance, and the inci-
dence rate of diabetic end-stage renal disease, internally
standardized for age, sex, and duration of diabetes, was
similar in those examined only once (and thus excluded
from the present study) and in those examined more often
(data not shown), suggesting that if subjects with frequent
examinations have different rates of renal disease than
those who have infrequent or no examinations, the magni-
tude of the difference is small.
In conclusion, the incidence rate of proteinuria in dia-
betic Pima Indians is increasing despite improvements in
plasma glucose and blood pressure. This contrasts sharply
with the declining incidence rate reported in Type 1
diabetes, which is attributable, in large part, to improve-
ments in glycemic control. If this trend is also occurring in
other Type 2 diabetic populations, the public health impli-
cations are profound. Given the rising incidence rate of
Type 2 diabetes worldwide, and its early age at onset in
many ethnic groups, the potential importance of the intra-
uterine environment in enhancing the risk of renal disease
in this Type of diabetes should not be overlooked.
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